BSE Live
Oct 03, 10:53Prev. Close
1182.45
Open Price
1191.35
Bid Price (Qty.)
1175.25 (6)
Offer Price (Qty.)
1188.60 (8)
NSE Live
Oct 03, 10:53Prev. Close
1177.30
Open Price
1177.30
Bid Price (Qty.)
1181.30 (1)
Offer Price (Qty.)
1183.10 (1)
Profit & Loss account of SMS Lifesciences India (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 278.45 | 371.05 | 231.33 | 225.99 | 0.00 | |
Less: Excise/Sevice Tax/Other Levies | 25.68 | 31.53 | 22.48 | 13.68 | 0.00 | |
Revenue From Operations [Net] | 252.77 | 339.52 | 208.85 | 212.31 | 0.00 | |
Total Operating Revenues | 256.92 | 344.15 | 212.99 | 215.89 | 0.00 | |
Other Income | 1.88 | 2.53 | 3.08 | 1.73 | 0.00 | |
Total Revenue | 258.81 | 346.68 | 216.07 | 217.62 | 0.00 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 155.75 | 238.47 | 135.01 | 123.68 | 0.00 | |
Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Operating And Direct Expenses | 37.56 | 47.77 | 39.51 | 42.01 | 0.00 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | 6.29 | -8.19 | -2.06 | -3.61 | 0.00 | |
Employee Benefit Expenses | 23.27 | 20.63 | 17.65 | 16.89 | 0.00 | |
Finance Costs | 5.09 | 5.46 | 4.18 | 6.16 | 0.00 | |
Depreciation And Amortisation Expenses | 7.24 | 5.77 | 5.70 | 5.55 | 0.00 | |
Other Expenses | 10.26 | 13.00 | 9.68 | 8.47 | 0.00 | |
Total Expenses | 245.47 | 322.92 | 209.67 | 199.16 | 0.00 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 13.34 | 23.76 | 6.40 | 18.46 | 0.00 | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Profit/Loss Before Tax | 13.34 | 23.76 | 6.40 | 18.46 | 0.00 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 3.25 | 6.30 | 1.70 | 6.00 | 0.00 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | 0.89 | 0.83 | -0.47 | -0.48 | 0.00 | |
Tax For Earlier Years | 0.05 | -0.01 | -1.34 | 0.00 | 0.00 | |
Total Tax Expenses | 4.19 | 7.13 | -0.10 | 5.52 | 0.00 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 9.15 | 16.63 | 6.50 | 12.94 | 0.00 | |
Profit/Loss From Continuing Operations | 9.15 | 16.63 | 6.50 | 12.94 | 0.00 | |
Profit/Loss For The Period | 9.15 | 16.63 | 6.50 | 12.94 | 0.00 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 30.26 | 55.02 | 21.50 | 42.81 | -1.85 | |
Diluted EPS (Rs.) | 30.26 | 55.02 | 21.50 | 42.81 | -1.85 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 0.00 | 15.00 | 0.00 | 0.00 | 0.00 |
08.09.2025
SMS Lifescience Standalone June 2025 Net Sales at Rs 79.04 crore, down 8.7% Y-o-Y
12.06.2025
SMS Lifescience Standalone March 2025 Net Sales at Rs 85.43 crore, down 1.1% Y-o-Y
04.06.2025
SMS Lifescience Consolidated March 2025 Net Sales at Rs 89.11 crore, down 0.98% Y-o-Y
04.03.2025
SMS Lifescience Consolidated December 2024 Net Sales at Rs 84.60 crore, up 17.41% Y-o-Y
08.09.2025
SMS Lifescience Standalone June 2025 Net Sales at Rs 79.04 crore, down 8.7% Y-o-Y
12.06.2025
SMS Lifescience Standalone March 2025 Net Sales at Rs 85.43 crore, down 1.1% Y-o-Y
04.06.2025
SMS Lifescience Consolidated March 2025 Net Sales at Rs 89.11 crore, down 0.98% Y-o-Y
04.03.2025
SMS Lifescience Consolidated December 2024 Net Sales at Rs 84.60 crore, up 17.41% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017